ReviewFrontiers in oncology2025

Biomarkers to optimize PSMA-targeted radioligand therapy for metastatic castration-resistant prostate cancer.

Himisha Beltran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.